Abstract

Objective To investigate the distribution of residual cancer cells (RCCs) in the bowel wall and its associated factors among patients with rectal cancer after preoperative volumetric modulated arc therapy (VMAT) with concurrent chemotherapy.Methods A retrospective analysis was performed on the clinical data of 178 patients with locally advanced rectal cancer who received VMAT with concurrent chemotherapy followed by surgery in our hospital from April 2011 to April 2013.There were 124 males and 54 females,and the age range was from 23 to 84 years.T1,T2,T3,and T4 rectal cancer was found in 1,2,73,and 102 patients,respectively.All the RCCs in surgical specimens from different layers of the bowel wall were evaluated pathologically.Between-group differences were evaluated by Fisher's exact test,and the associations of preoperative T and N stages with postoperative ypT and distribution of RCCs in the bowel wall were determined by Spearman rank correlation test.Results The rates of RCCs in the mucosa,submucosa,muscularis propria,and subserosa/perirectal fat surgical specimens were 15.2%,27.0%,46.6%,and 46.1%,respectively,for all patients,and were 20.0%,36.7%,69.2%,and 68.3%,respectively,for 120 patients with ypT2-4 disease.Of all patients surgically treated,52 had ypT0 disease,2 had ypTis disease,4 had ypT1 disease,38 had ypT2 disease,77 had ypT3 disease,and 5 had ypT4 disease.The rate of ypT0 in 36 ypN (+) patients was significantly lower than that in 140 ypN0 patients (3% vs.35.7%,P =0.000),yet its rate of RCCs in the subserosa/perirectal fat was significantly higher than that in ypN0 patients (83% vs.36.4%,P =0.000).The rate of ypT0 was significantly higher in 73 T3 patients than in 102 T4 patients (37% vs.21.6%,P =0.025).Conclusions Most RCCs in the bowel wall of patients treated with preoperative VMAT with concurrent chemotherapy are distributed within or below the muscularis propria,which are significantly associated with ypT,ypN,and T stages.The value of biopsy for primary rectal lesions after neoadjuvant CRT may be very limited. Key words: Rectal neoplasms/preoperative chemoradiotherapy; Volumetric modulated arc therapy; Residual cancer cell

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.